ORANY
ORANGE
$20.56
+0.19%
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$1.7M
Inst. Activity1 buys / 5 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — fully exited their positions in
INST-CLUSTER — Impact 7/10
Inst.
THORNBURG INVESTMENT MANAGEMENT INC — TRIM
667,110 shares ($6.6M)
Inst.
BARCLAYS PLC — DOUBLED
230,672 shares ($2.3K)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.39
Current $20.56
Low $18.10
Median $22.58
High $23.50
3 analysts
$18.10
$23.50
Analyst Ratings
4Strong Buy
9Buy
10Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $1.39 ▼ -1.3% | $1.39 — $1.39 | 36% YoY | 1 |
| Next FY | $1.57 ▼ -1.9% | $1.57 — $1.57 | 13% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RHUMBLINE ADVISERS | $1.7M | — |
1 institutional holders with $1.7M total value (83,182 shares) as of 2026-Q1. Top holders: RHUMBLINE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RHUMBLINE ADVISERS | 83,182 | $1.7M | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| THORNBURG INVESTMENT MANAGEMENT INC | TRIM | 895,576 | 667,110 | -25.5% | $6.6M | 2024-Q4 |
| BARCLAYS PLC | DOUBLED | 19,380 | 230,672 | +1090.3% | $2.3K | 2024-Q4 |
| MORGAN STANLEY | EXIT | 3,365,406 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BlackRock, Inc. | EXIT | 2,500,684 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BRANDES INVESTMENT PARTNERS, LP | EXIT | 1,848,118 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | EXIT | 952,434 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 563,123 | 952,434 | +69.1% | $10.9M | 2024-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 459,826 | 631,991 | +37.4% | $8.1M | 2024-Q3 |
| FMR LLC | DOUBLED | 292,290 | 640,524 | +119.1% | $7.4M | 2024-Q3 |
| Point72 Asset Management, L.P. | DOUBLED | 42,500 | 221,800 | +421.9% | $2.5M | 2024-Q3 |
| Mariner, LLC | ADD | 148,467 | 193,020 | +30.0% | $2.2M | 2024-Q3 |
| STIFEL FINANCIAL CORP | ADD | 152,881 | 191,733 | +25.4% | $2.2M | 2024-Q3 |
| AMERIPRISE FINANCIAL INC | DOUBLED | 81,446 | 164,407 | +101.9% | $1.9M | 2024-Q3 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | ADD | 112,728 | 170,972 | +51.7% | $1.9M | 2024-Q3 |
| NORGES BANK | TRIM | 175,288 | 113,600 | -35.2% | $1.3M | 2024-Q3 |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 211,216 | 111,477 | -47.2% | $1.3M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 52,561 | 104,033 | +97.9% | $1.2M | 2024-Q3 |
| Cerity Partners LLC | ADD | 72,452 | 100,856 | +39.2% | $1.2M | 2024-Q3 |
| HighTower Advisors, LLC | DOUBLED | 10,129 | 98,446 | +871.9% | $1.1M | 2024-Q3 |
| Cresset Asset Management, LLC | ADD | 40,738 | 57,643 | +41.5% | $661.7K | 2024-Q3 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 77,306 | 54,603 | -29.4% | $626.8K | 2024-Q3 |
| Invesco Ltd. | ADD | 17,292 | 33,201 | +92.0% | $381.1K | 2024-Q3 |
| Centiva Capital, LP | DOUBLED | 10,846 | 27,150 | +150.3% | $311.7K | 2024-Q3 |
| Russell Investments Group, Ltd. | ADD | 11,353 | 17,987 | +58.4% | $206.5K | 2024-Q3 |
| CAPTRUST FINANCIAL ADVISORS | ADD | 13,362 | 16,721 | +25.1% | $192.0K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 57% buy across 23 analysts — 4 strong buy, 9 buy, 10 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.39 mean target
$18.10 Low
$23.50 High
| Metric | Value |
|---|---|
| Current Price | $20.56 |
| Target Low | $18.10 |
| Target Mean | $21.39 |
| Target Median | $22.58 |
| Target High | $23.50 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $10.0B | 0.9% | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $10.0B | 0.4% | — |
| Current FY 2026-12-31 |
$1.39 | $1.39 | $1.39 | 36.4% | -1.3% | 0↑ 1↓ | $44.7B | 10.6% | 1 |
| Next FY 2027-12-31 |
$1.57 | $1.57 | $1.57 | 13.3% | -1.9% | 0↑ 1↓ | $49.0B | 9.8% | 1 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 9 | 10 | 0 | 0 | 57% | |
| May 1, 2026 | 3 | 9 | 11 | 0 | 0 | 52% | |
| Apr 1, 2026 | 4 | 9 | 11 | 0 | 0 | 54% | |
| Mar 1, 2026 | 5 | 10 | 9 | 0 | 0 | 63% | |
| Feb 1, 2026 | 6 | 12 | 6 | 0 | 0 | 75% | |
| Jan 1, 2026 | 5 | 12 | 7 | 0 | 0 | 71% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.